These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23772497)

  • 21. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary aldosteronism.
    Carey RM
    Horm Res; 2009 Jan; 71 Suppl 1():8-12. PubMed ID: 19153497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia.
    Li N; Wang M; Wang H; Zhang D; Wang X; Zu F; Chang G; Zhou K
    Clin Exp Hypertens; 2013; 35(3):175-82. PubMed ID: 22913631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.
    Armanini D; Fiore C; Pellati D
    Hypertension; 2007 Oct; 50(4):e69-70. PubMed ID: 17709652
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Drug-resistant hypertension and primary aldosteronism.
    Vidal-Petiot E
    Eur J Prev Cardiol; 2022 Mar; 29(2):e82-e84. PubMed ID: 34109384
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 10. Obesity-related disorders].
    Ishigaki Y; Katagiri H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):895-901. PubMed ID: 23772504
    [No Abstract]   [Full Text] [Related]  

  • 27. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 28. [Normoaldosterone spironolactone sensitive hypertension--a case report].
    Krysiak R; Okopień B; Herman ZS
    Pol Arch Med Wewn; 2005 Oct; 114(4):978-81. PubMed ID: 16789524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response to thiazides and spironolactone in primary aldosteronism.
    Gwinup G; Steinberg T
    Arch Intern Med; 1967 Oct; 120(4):436-43. PubMed ID: 6058098
    [No Abstract]   [Full Text] [Related]  

  • 30. [New data on mineralocorticoid hormones. Physiopathological implications].
    Corvol P; Jeunemaitre X
    Presse Med; 1995 Sep; 24(27):1235-7. PubMed ID: 7501603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 5. Rheumatic diseases--diagnosis and treatments].
    Mimura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):862-8. PubMed ID: 23772499
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
    Kaku K; Enya K; Sugiura K; Totsuka N
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():73-84. PubMed ID: 22106979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment: 9. Dyslipidemia].
    Arai H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):890-4. PubMed ID: 23772503
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment; 12. Osteoporosis].
    Okada Y; Mori H; Tanaka Y
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):907-13. PubMed ID: 23772506
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypertension in the course of primary aldosteronism during pregnancy].
    Wyskida M; Wyskida K; Olszanecka-Glinianowicz M; Maruniak-Chudek I; Sikora J; Chudek J
    Postepy Hig Med Dosw (Online); 2015 Feb; 69():207-13. PubMed ID: 25720606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary aldosteronism and its importance to the anaesthetist.
    Shipton EA; Hugo JM
    S Afr Med J; 1982 Jul; 62(2):60-3. PubMed ID: 7046100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resistant hypertension: often the therapy is to blame].
    Holzgreve H
    MMW Fortschr Med; 2016 Mar; 158(6):44. PubMed ID: 27084156
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.